| Serial Number | 90716777 |
| Word Mark | SUVALENT |
| Filing Date | Monday, May 17, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, May 27, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 1, 2022 |
| Goods and Services | Pharmaceuticals and medicines for the prevention and treatment of cancer; pharmaceuticals and medicines for the identification and treatment of tumors; pharmaceuticals preparations in the form of capsules, tablets, and powders for the treatment of cancer; intravenous pharmaceuticals, namely, vials for intravenous administration sold filled with preparations for the treatment of cancer; biological preparations for the prevention and treatment of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in the for testing and treatment of cancer; medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations in the nature of drug delivery agents that facilitate administration of other pharmaceutical preparations into the human body for enhanced treatment of cancer |
| Goods and Services | Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; testing, inspection, research, or development of pharmaceutical preparations for the prevention and treatment of cancer; research and development of pharmaceuticals and medicines for the identification and treatment of tumors; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the fields of pharmaceutical and biological preparations; development of new technology for others in the fields of pharmaceuticals, biotechnology, and medicine; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; biological research and analysis; chemical research; medical research, namely, conducting clinical trials for others |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 16, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 16, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Suvalent Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Thousand Oaks, CA 91320 |
| Party Name | Suvalent Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Thousand Oaks, CA 91320 |
| Event Date | Event Description |
| Thursday, May 20, 2021 | NEW APPLICATION ENTERED |
| Monday, August 16, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 25, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, March 1, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 1, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, January 26, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 9, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, October 6, 2022 | SOU EXTENSION 1 FILED |
| Tuesday, April 26, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, October 6, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 6, 2022 | SOU EXTENSION 1 GRANTED |
| Friday, April 14, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 14, 2023 | SOU EXTENSION 2 FILED |
| Friday, April 14, 2023 | SOU EXTENSION 2 GRANTED |
| Tuesday, October 24, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, October 27, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, May 27, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, July 12, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Tuesday, October 24, 2023 | SOU EXTENSION 3 GRANTED |
| Saturday, October 8, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, April 18, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 24, 2023 | SOU EXTENSION 3 FILED |